Skip to content
Amsterdam UMC Websites
Healthcare
Nieuws & organisatie (NL)
News & corporate
Research
Emma Children's Hospital
Careers
Menu
Menu
Research
Research
Search
Search
Amsterdam UMC Research
Conducting Research
Research Institutes
Research Institutes
Cancer Center Amsterdam
Amsterdam Cardiovascular Sciences
Amsterdam Gastroenterology Endocrinology Metabolism
Amsterdam Institute for Immunology and Infectious diseases
Amsterdam Movement Sciences
Amsterdam Neuroscience
Amsterdam Public Health
Amsterdam Reproduction & Development
Researchers
Researchers
All researchers
Careers at Amsterdam UMC
About Amsterdam UMC Research
About Amsterdam UMC Research
Organization
About Research Support
Supporting Committees
Departments
News
News
News
Research highlights
Events
Research Roadmap
Research Roadmap
Design & Preparation
Conduct & Collecting data
Closure, Publishing & Archiving
Core facilities
Core facilities
Biobank
CRISPR Center
Functional Genomic Screening
Genomics
Induced Pluripotent Stem Cells
Metabolomics
Microscopy and Cytometry
OncoProteomics
Research Imaging Core Center
Research Support
Research Support
Legal Research Support
Medical library
Methodological and statistical support
Research Code
Data Management
Grant Support
Policy Office
All support
Contact
Career at Amsterdam UMC
About Amsterdam UMC
Contact
Career at Amsterdam UMC
About Amsterdam UMC
Other channels of
Amsterdam UMC
Healthcare
Nieuws & organisatie (NL)
News & corporate
Research
Emma Children's Hospital
Careers
Sluit menu
Search
Cancer Center Amsterdam
Navigate to
Home
Research
Researchers
Research highlights
Research programs
Research information
Research groups
News
Events
Grant information
Education
PhD candidates
BSc/MSc students
Postdocs
Partnering
About
Research
Research highlights CCA
DIPLOMA trial: a clinical study to determine safety and effectiveness of minimally invasive versus open surgery in pancreatic cancer
The DIPLOMA trial aims to answer concerns about the use of minimally invasive surgery for the treatment of pancreatic cancer.
Ongoing
Fatigue, fear of recurrence and depression after cancer: personalized treatment
Can cancer survivors with fatigue, fear of recurrence and depression after cancer be more effectively treated if protocols are personalized?
Ongoing
From fundamental research to clinical trial in two years – the Cancer Center Amsterdam way
An example of how the multidisciplinary environment at Cancer Center Amsterdam allows rapid translation of fundamental science to clinical applications.
Ongoing
Germline biomarkers of melanoma immunotherapy: an international consortium
Biomarkers that predict immunotherapy treatment success or risk of toxicity are urgently needed to increase the clinical benefit for metastatic melanoma patients.
Ongoing
Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1)
This study evaluates whether a nationwide program of best practices in pancreatic cancer care can improve 1-year overall survival and quality of life.
Ongoing
Major breakthroughs in lymphoma and leukemia therapy: Ibrutinib and Venetoclax
Important contributions are made to preclinical and clinical investigations involving targeted therapies for lymphoma and leukemia patients: from bench to bedside, and back!
Completed
Oncokompas, a fully automated behavioral intervention technology to support cancer survivors
Oncokompas helps cancer survivors self-monitor symptoms, obtain automated tailored information and receive personalized access to supportive care options.
Ongoing
Radiomics and machine learning for response prediction in Diffuse Large B-Cell Lymphoma patients using advanced medical imaging technologies
Radiomics technology extracts a large number of features from medical imaging to predict treatment response.
Ongoing
The IMPROVE trial: Cervical cancer screening in the Netherlands gets a boost
Self-sampling in cervical cancer screening proved to be as accurate as clinician-based sampling and can boost participation in the national screening program.
Ongoing
The role of cellular plasticity in cancer
Cancer cell plasticity, the ability of cells to change their identity, is involved in formation of metastasis, resistance to therapies and disease recurrence.
Ongoing
Training Network for Optimizing Adoptive T Cell Therapy of Cancer (T-OP)
The clinical implementation of immunotherapeutics has established T cells as efficient anti-cancer weapons.
Ongoing
1
Back to top